A trial to determine if stereotactic body radiation therapy (SBRT) is superior to hypofractionated intensity modulated radiation therapy (IMRT) in the treatment of localised intermediate risk prostate cancer has opened at the Beacon Hospital in Dublin. The trial is sponsored in Ireland by NRG Oncology (International) and Cancer Trials Ireland and will recruit 6 to […]

View a video of our presentation to the Joint Oireachtas Committee for Health where we pressed the case to reverse the 20% cuts to cancer trials research.

“By increasing investment in cancer trials infrastructure, we could be offering Irish cancer patients more options and potentially better outcomes. Cancer trials can extend lives and give people a better quality of life. When I am in the clinic with a cancer patient, there are times I want to be able to offer more than […]

Extract from presentation by Eibhlin Mulroe to the Joint Oireachtas Committee on Health on 13th March 2019. “Due to our reduced funding, we have had to decline opening clinically important academic trials in Ireland. These trials would benefit people with a range of cancers including lymphoma, testicular and endometrial cancer. We are unable to be […]

“We need to fight for the best clinical trials with the most promising drugs …. Professor Cathy Kelly Consultant Medical Oncologist in Health News Ireland’s feature on women’s health in today’s Irish Independent: Unsung heroes: women living with metastatic breast cancer http://www.healthnews.ie/womens-health/unsung-heroes-women-living-with-metastatic-breast-cancer

Speaking at the Joint Committee on Health this morning (13th March) Cancer Trials Ireland highlighted that due to funding cut backs of €750,000 per year it had has not been able to open clinically important cancer trials in Ireland that could improve the outcomes for people with cancer. Eibhlín Mulroe, CEO, Cancer Trials Ireland, said […]

Read the latest project news in our Winter 2019 COLOSSUS newsletter. Get an update on the COLOSSUS translational trial and read the dissemination highlights too. In this edition, our ‘Partner in the Spotlight” is Cancer Trials Ireland. Download the newsletter here.

Congratulations to Dr Mihai and the Clinical Trials Research Unit at Beacon Hospital on their input to the international Oligorecurrent Stereotactic trial which indicates stereotactic radiation can extend long-term survival for some patients with stage-IV cancers while maintaining their quality of life. The study is published in the January issue of International Journal of Radiation […]

We’re delighted to be working with colleagues around the world and playing our part in discovering better diagnostics and treatments.